Amperos Health | $4,200,000 | (Jun 5, 2025)
Manex AI | $9,142,230 | (Jun 5, 2025)
Aive | $13,700,350 | (Jun 5, 2025)
Certified by Founder
Lodge
ARTBIO
start up
United States
- Cambridge, Massachusetts
- 08/12/2023
- Series A
- $90,000,000
ARTBIO is a clinical-stage radiopharmaceutical biotechnology company focused on developing a new class of alpha radioligand therapies (ART). Our unique patient-centric approach is underpinned by a deep understanding of cancer biology and the infrastructure needed to effectively design, manufacture, and distribute our therapies.
- Industry Biotechnology Research
- Website https://artbio.com/
- LinkedIn https://www.linkedin.com/company/artbio-inc/
Related People
Emanuele OstuniFounder
Switzerland -
Reinach, Basel-Country
Specialties: Commercial execution, Strategy, M&A, Business Development, Entrepreneurship,
Obvio | $22,000,000 | (Jun 5, 2025)
Portless | $18,000,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)
Delpha | $2,000,000 | (Jun 5, 2025)
fabriq | $25,000,000 | (Jun 5, 2025)
Compyl | $12,000,000 | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
myLaurel® | $12,000,000 | (Jun 4, 2025)